A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience
Myung Jin Oh, Heon Ju Lee
Clin Mol Hepatol. 2013;19(1):51-59.   Published online 2013 Mar 25     DOI: https://doi.org/10.3350/cmh.2013.19.1.51
Citations to this article as recorded by Crossref logo
Pharmacotherapy-Induced Hepatitis B Reactivation Among Patients With Prior Functional Cure: A Systematic Review
Rhiannon M. Bath, Brandelyn E. Doering, Michael D. Nailor, Kellie J. Goodlet
Annals of Pharmacotherapy.2019; 53(3): 294.     CrossRef
Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management
Ranjit Chauhan, Shilpa Lingala, Chiranjeevi Gadiparthi, Nivedita Lahiri, Smruti R Mohanty, Jian Wu, Tomasz I Michalak, Sanjaya K Satapathy
World Journal of Hepatology.2018; 10(3): 352.     CrossRef
Antiviral therapies for managing viral hepatitis in lymphoma patients
Michele Merli, Sara Rattotti, Manuel Gotti, Luca Arcaini
Expert Opinion on Pharmacotherapy.2017; 18(4): 363.     CrossRef
Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis
Zilin Tang, Xiaodong Li, Shunquan Wu, Yan Liu, Yan Qiao, Dongping Xu, Jin Li
Hepatology International.2017; 11(5): 429.     CrossRef
Risk factors and outcomes of hepatitis B virus reactivation in hepatitis B surface antigen negative patients with hematological malignancies
Ji Won Han, Hyun Yang, Hae Lim Lee, Si Hyun Bae, Jong Young Choi, Jong-Wook Lee, Hee Je Kim, Seok Lee, Seok Goo Cho, Chang Ki Min, Dong Wook Kim, Seung Kew Yoon
Hepatology Research.2016; 46(7): 657.     CrossRef
High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma
Yuri Cho, Su Jong Yu, Eun Ju Cho, Jeong-Hoon Lee, Tae Min Kim, Dae Seog Heo, Yoon Jun Kim, Jung-Hwan Yoon
Journal of Medical Virology.2016; 88(6): 1010.     CrossRef
Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders
Mauro Viganò, Giuseppe Serra, Giovanni Casella, Glenda Grossi, Pietro Lampertico
Expert Opinion on Biological Therapy.2016; 16(7): 917.     CrossRef
Impfungen bei Immundefekten/Immunsuppression – Expertenstatement und Empfehlungen
Ursula Wiedermann, Harald H. Sitte, Heinz Burgmann, Alexander Eser, Petra Falb, Heidemarie Holzmann, Maria Kitchen, Marcus Köller, Herwig Kollaritsch, Michael Kundi, Hans Lassmann, Ingomar Mutz, Winfried F. Pickl, Elisabeth Riedl, Maria Sibilia, Florian T
Wiener klinische Wochenschrift.2016; 128(S4): 337.     CrossRef
Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000
Elio Castagnola, Eliana Ruberto, Alfredo Guarino
World Journal of Gastroenterology.2016; 22(25): 5853.     CrossRef
Occult hepatitis B virus infection of hemodialysis patients: A cross-sectional study in a hepatitis B virus-endemic region
So Mi Kim, Hyun Woo Kim, Ji Eun Lee, Eun Kyoung Lee, Hyun Deok Shin, Il Han Song
Hemodialysis International.2015; 19(1): 66.     CrossRef
Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis
Fernando Valenzuela, Kim A Papp, David Pariser, Stephen K Tyring, Robert Wolk, Marjorie Buonanno, Jeff Wang, Huaming Tan, Hernan Valdez
BMC Dermatology.2015;[Epub]     CrossRef
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis
L. Mozessohn, K. K. W. Chan, J. J. Feld, L. K. Hicks
Journal of Viral Hepatitis.2015; 22(10): 842.     CrossRef
American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
Robert P. Perrillo, Robert Gish, Yngve T. Falck-Ytter
Gastroenterology.2015; 148(1): 221.     CrossRef
Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy
Mauro Viganò, Giampaolo Mangia, Pietro Lampertico
Expert Opinion on Biological Therapy.2014; 14(7): 1019.     CrossRef
De la indiferencia a la resistencia. Los sectores populares y la Guerra de Independencia en el norte de Chile (1817-1823)
Igor Goicovic Donoso
Revista de Indias.2014; 74(260): 129.     CrossRef